Company name | Market Cap | Growth score | Revenue Growth
(5Y CAGR) | Revenue Growth
(YoY) | Revenue Growth
(FWD) | EPS Growth
(5Y CAGR) | EPS Growth
(YoY) | EPS Growth
(FWD) | FCF Growth
(5Y CAGR) | FCF Growth
(YoY) |
$34.6B | 7.4 | 10.1% | 6.5% | 5.6% | 16.8% | 5.8% | 11.0% | 21.3% | 3.3% | |
$197.8B | 6.2 | 10.9% | 0.1% | 2.4% | 12.4% | 6.8% | 40.5% | 12.4% | 4.9% | |
$154.1B | 4.4 | 3.7% | (0.1%) | 1.0% | 5.4% | (17.4%) | 43.2% | 9.8% | (8.4%) | |
$34.4B | 5.8 | 4.5% | (3.0%) | 3.4% | 12.2% | 3.1% | 25.4% | 18.7% | (14.6%) | |
$33.7B | 6.8 | 6.8% | 2.5% | 3.2% | N/A | N/A | 57.0% | 20.4% | 40.9% | |
$25.2B | 6.1 | 5.2% | 2.2% | 1.1% | 12.2% | 12.6% | 5.1% | 11.3% | 0.5% | |
$21.7B | 4.7 | 4.2% | 0.1% | 4.0% | 4.0% | (1.2%) | 19.7% | 5.3% | 40.1% | |
$19.9B | 6.9 | 41.2% | 56.7% | 12.8% | (3.3%) | (59.7%) | 39.1% | N/A | N/A | |
$18.5B | 4.5 | 5.0% | 6.7% | 9.2% | 4.2% | 2.9% | 24.4% | 1.5% | 5.2% | |
$15.1B | 7.8 | 24.2% | 2.0% | 0.8% | 7.0% | 28.8% | 45.2% | 25.3% | 10.5% | |
$13.9B | 4.9 | 4.3% | (2.9%) | (1.0%) | N/A | 4.6% | (158.6%) | (3.7%) | 146.8% |
The IDEXX Laboratories, Inc. (IDXX) revenue growth is 6.5%, which is lower than the industry median of 4.9% and the 5-year historical average of 10.5%.
The IDEXX Laboratories, Inc. (IDXX) operating income growth is 3.0%, compared to the industry median of 3.0% and the 5-year historical average of 16.7%.
The IDEXX Laboratories, Inc. (IDXX) EPS growth is 5.8%, compared to the industry median of (15.3%) and the 5-year historical average of 18.6%.
The IDEXX Laboratories, Inc. (IDXX) Free Cash Flow growth is 3.3%, compared to the industry median of 10.7% and the 5-year historical average of 32.2%.